Prikaz osnovnih podataka o dokumentu
Novelties in the treatment of osteoarthritis
Novine u lečenju osteoartritisa
dc.creator | Stepanović-Petrović, Radica | |
dc.creator | Tomić, Maja | |
dc.date.accessioned | 2019-09-02T11:56:50Z | |
dc.date.available | 2019-09-02T11:56:50Z | |
dc.date.issued | 2016 | |
dc.identifier.issn | 0004-1963 | |
dc.identifier.uri | https://farfar.pharmacy.bg.ac.rs/handle/123456789/2775 | |
dc.description.abstract | Goal of osteoarthritis (OA) treatment is to relieve the pain and to reduce the loss of patient's physical functionality. Therapy consists of: nonpharmacological measures, pharmacotherapy and surgery. Although nonpharmacological approach represents a basis of OA treatment, pharmacotherapy is an important adjunct. Medications that are used in this disease can be administered orally, topically or intra-articularly. In OA treatment the following medications are used: analgesics, glucosamine- and chondroitin-based preparations, glucocorticoids and hyaluronic acid (intra-articular administration) and other medications. Nonopioid analgesics represent a corner stone in OA pharmacotherapy. Treatment initiation with paracetamol (acetaminophen) and/or topical nonsteroidal anti-inflammatory drug (NSAID) is recommended. Afterwards, in a case of complete or partial treatment failure, oral traditional NSAID (tNSAID) or selective COX-2 inhibitor should be used, or opioids as a substitute or an adjunct. Glucosamine- and chondroitin-based preparations are not recommended for OA treatment. Intra-articular use of glucocorticoid (triamcinolon) can lead to short lasting removal of pain and inflammation, while intra-articular use of hyaluronic acid is not recommended. Surgical treatment is important for heavy joint damage and in the case of failure of other treatment modalities. | en |
dc.description.abstract | Cilj lečenja osteoartritisa (OA) je ublažiti bol i smanjiti gubitak fizičke funkcionalnosti pacijenta. Terapija se sastoji od: nefarmakoloških mera, farmakoterapije i hirurgije. Mada nefarmakološki pristup predstavlja osnovu lečenja OA, farmakoterapija je važan dodatak lečenju. Lekovi koji se primenjuju u ovoj bolesti mogu se davati per os, topikalno ili intraartikularno. U lečenju OA koriste se sledeći lekovi: analgetici, preparati na bazi glukozamina i hondroitina, glukokortikoidi i hijaluronska kiselina (intraartikularna primena) i ostali lekovi. Kamen temeljac u farmakoterapiji OA čine neopioidni analgetici. Preporučuje se otpočinjanje terapije paracetamolom i/ili topikalnim nesteroidnim antiinflamatornim lekom (NSAIL), nakon čega u slučaju potpunog ili delimičnog neuspeha treba primeniti oralne tradicionalne NSAIL/selektivne inhibitore ciklooksigenaze 2, ili opioide kao zamenu ili dodatak terapiji. Preparati na bazi glukozamina i hondroitina se ne preporučuju za lečenje OA. Intraartikularna primena glukokortikoida (triamcinolon) može da dovede do kratkotrajnog otklanjanja bola i inflamacije, dok se intraartikularna primena hijaluronske kiseline ne preporučuje. Hirurško lečenje je važno kod teških oštećenja zglobova u OA i neuspeha ostalih oblika lečenja. | sr |
dc.publisher | Savez farmaceutskih udruženja Srbije, Beograd | |
dc.rights | openAccess | |
dc.rights.uri | https://creativecommons.org/licenses/by-sa/4.0/ | |
dc.source | Arhiv za farmaciju | |
dc.subject | non-opioid analgesics | en |
dc.subject | tramadol | en |
dc.subject | glucosamine | en |
dc.subject | chondroitin | en |
dc.subject | neopioidni analgetici | sr |
dc.subject | tramadol | sr |
dc.subject | glukozamin | sr |
dc.subject | hondroitin | sr |
dc.title | Novelties in the treatment of osteoarthritis | en |
dc.title | Novine u lečenju osteoartritisa | sr |
dc.type | article | |
dc.rights.license | BY-SA | |
dcterms.abstract | Степановић-Петровић, Радица; Томић, Маја; Новине у лечењу остеоартритиса; Новине у лечењу остеоартритиса; | |
dc.citation.volume | 66 | |
dc.citation.issue | 6 | |
dc.citation.spage | 257 | |
dc.citation.epage | 266 | |
dc.citation.other | 66(6): 257-266 | |
dc.citation.rank | M53 | |
dc.identifier.doi | 10.5937/arhfarm1606257S | |
dc.identifier.scopus | 2-s2.0-85019070103 | |
dc.identifier.fulltext | https://farfar.pharmacy.bg.ac.rs//bitstream/id/1416/2773.pdf | |
dc.type.version | publishedVersion |